Improving docking and virtual screening performance using AlphaFold2 multi-state modeling for kinases.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 13 08 2024
accepted: 04 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Structure-based virtual screening (SBVS) is a crucial computational approach in drug discovery, but its performance is sensitive to structural variations. Kinases, which are major drug targets, exemplify this challenge due to active site conformational changes caused by different inhibitor types. Most experimentally determined kinase structures have the DFGin state, potentially biasing SBVS towards type I inhibitors and limiting the discovery of diverse scaffolds. We introduce a multi-state modeling (MSM) protocol for AlphaFold2 (AF2) kinase structures using state-specific templates to address these challenges. Our comprehensive benchmarks evaluate predicted model qualities, binding pose prediction accuracy, and hit compound identification through ensemble SBVS. Results demonstrate that MSM models exhibit comparable or improved structural accuracy compared to standard AF2 models, enhancing pose prediction accuracy and effectively capturing kinase-ligand interactions. In virtual screening experiments, our MSM approach consistently outperforms standard AF2 and AF3 modeling, particularly in identifying diverse hit compounds. This study highlights the potential of MSM in broadening kinase inhibitor discovery by facilitating the identification of chemically diverse inhibitors, offering a promising solution to the structural bias problem in kinase-targeted drug discovery.

Identifiants

pubmed: 39448664
doi: 10.1038/s41598-024-75400-6
pii: 10.1038/s41598-024-75400-6
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Ligands 0
Protein Kinases EC 2.7.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25167

Subventions

Organisme : National Research Foundation of Korea
ID : 2022M3E5F3081268
Organisme : Korea Environmental Industry and Technology Institute
ID : RS-2023-00219144
Organisme : Ministry of Science and ICT, South Korea
ID : IITP-2024-RS-2022-00156439
Organisme : College of Medicine, Korea University
ID : K2327351

Informations de copyright

© 2024. The Author(s).

Références

Shin, W. H., Christoffer, C. W., Wang, J. & Kihara, D. PL-PatchSurfer2: Improved local surface matching-based virtual screening method that is tolerant to target and ligand structure variation. J. Chem. Inf. Model. 56(9), 1676–1691 (2016).
doi: 10.1021/acs.jcim.6b00163 pubmed: 27500657 pmcid: 5037053
Bordogna, A., Pandini, A. & Bonati, L. Predicting the accuracy of protein-ligand docking on homology models. J. Comput. Chem. 32(1), 81–98 (2011).
doi: 10.1002/jcc.21601 pubmed: 20607693 pmcid: 3057020
Fan, H. et al. Molecular docking screens using comparative models of proteins. J. Chem. Inf. Model. 49(11), 2512–2527 (2009).
doi: 10.1021/ci9003706 pubmed: 19845314 pmcid: 2790034
Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16(1), 19–34 (2017).
doi: 10.1038/nrd.2016.230 pubmed: 27910877
Gaulton, A. et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40(Database issue), D1100–D1007 (2012).
doi: 10.1093/nar/gkr777 pubmed: 21948594
McClendon, C. L., Kornev, A. P., Gilson, M. K. & Taylor, S. S. Dynamic architecture of a protein kinase. Proc. Natl. Acad. Sci. U S A. 111(43), E4623–4631 (2014).
doi: 10.1073/pnas.1418402111 pubmed: 25319261 pmcid: 4217441
Hari, S. B., Merritt, E. A. & Maly, D. J. Sequence determinants of a specific inactive protein kinase conformation. Chem. Biol. 20(6), 806–815 (2013).
doi: 10.1016/j.chembiol.2013.05.005 pubmed: 23790491 pmcid: 3742363
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature. 596(7873), 583–589 (2021).
doi: 10.1038/s41586-021-03819-2 pubmed: 34265844 pmcid: 8371605
Baek, M. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science. 373(6557), 871–876 (2021).
doi: 10.1126/science.abj8754 pubmed: 34282049 pmcid: 7612213
Heo, L. & Feig, M. Multi-state modeling of G-protein coupled receptors at experimental accuracy. Proteins. 90(11), 1873–1885 (2022).
doi: 10.1002/prot.26382 pubmed: 35510704 pmcid: 9561049
Modi, V. & Dunbrack, R. L. Jr Defining a new nomenclature for the structures of active and inactive kinases. Proc. Natl. Acad. Sci. U S A. 116(14), 6818–6827 (2019).
doi: 10.1073/pnas.1814279116 pubmed: 30867294 pmcid: 6452665
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold3. Nature. 630(8016), 493–500 (2024).
doi: 10.1038/s41586-024-07487-w pubmed: 38718835 pmcid: 11168924
Meng, Y., Lin, Y. L. & Roux, B. Computational study of the DFG-flip conformational transition in c-Abl and c-Src tyrosine kinases. J. Phys. Chem. B. 119(4), 1443–1456 (2015).
doi: 10.1021/jp511792a pubmed: 25548962
Meng, Y., Pond, M. P. & Roux, B. Tyrosine kinase activation and conformational flexibility: Lessons from src-family tyrosine kinases. Acc. Chem. Res. 50(5), 1193–1201 (2017).
doi: 10.1021/acs.accounts.7b00012 pubmed: 28426203 pmcid: 6602532
Haldane, A., Flynn, W. F., He, P., Vijayan, R. S. & Levy, R. M. Structural propensities of kinase family proteins from a Potts model of residue co-variation. Protein Sci. 25(8), 1378–1384 (2016).
doi: 10.1002/pro.2954 pubmed: 27241634 pmcid: 4972195
Carles, F., Bourg, S., Meyer, C. & Bonnet, P. PKIDB: A curated, annotated and updated database of protein kinase inhibitors in clinical trials. Molecules. 23(4), 908 (2018).
doi: 10.3390/molecules23040908 pubmed: 29662024 pmcid: 6017449
Mysinger, M. M., Carchia, M., Irwin, J. J. & Shoichet, B. K. Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. J. Med. Chem. 55(14), 6582–6594 (2012).
doi: 10.1021/jm300687e pubmed: 22716043 pmcid: 3405771
Chen, V. B. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D. 66(1), 12–21 (2010).
doi: 10.1107/S0907444909042073
Kanev, G. K., de Graaf, C., Westerman, B. A., de Esch, I. J. P. & Kooistra, A. J. KLIFS: An overhaul after the first 5 years of supporting kinase research. Nucleic Acids Res. 49(D1), D562–D569 (2021).
doi: 10.1093/nar/gkaa895 pubmed: 33084889
Zhang, Y. & Skolnick, J. Scoring function for automated assessment of protein structure template quality. Proteins. 57(4), 702–710 (2004).
doi: 10.1002/prot.20264 pubmed: 15476259
Santos-Martins, D. et al. Accelerating AutoDock4 with GPUs and gradient-based local search. J. Chem. Theory Comput. 17(2), 1060–1073 (2021).
doi: 10.1021/acs.jctc.0c01006 pubmed: 33403848 pmcid: 8063785
Shin, W. H., Kim, J. K., Kim, D. S. & Seok, C. GalaxyDock2: Protein-ligand docking using beta-complex and global optimization. J. Comput. Chem. 34(30), 2647–2656 (2013).
doi: 10.1002/jcc.23438 pubmed: 24108416
Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2010).
doi: 10.1002/jcc.21334 pubmed: 19499576 pmcid: 3041641
Lee, J. & Seok, C. A statistical rescoring scheme for protein-ligand docking: Consideration of entropic effect. Proteins. 70(3), 1074–1083 (2008).
doi: 10.1002/prot.21844 pubmed: 18076034
Adasme, M. F. et al. PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49(W1), W530–534 (2021).
doi: 10.1093/nar/gkab294 pubmed: 33950214 pmcid: 8262720
Truchon, J. F. & Bayly, C. I. Evaluating virtual screening methods: Good and bad metrics for the early recognition problem. J. Chem. Inf. Model. 47(2), 488–508 (2007).
doi: 10.1021/ci600426e pubmed: 17288412
Landrum, G. & RDKit Open-source cheminformatics 2006. Accessed (2022).
Butina, D. Unsupervised data base clustering based on daylight’s fingerprint and Tanimoto similarity: A fast and automated way to cluster small and large data set. J. Chem. Inf. Comput. Sci. 39(4), 747–750 (1999).
Irwin, J. J. & Shoichet, B. K. ZINC–a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45(1), 177–182 (2005).
doi: 10.1021/ci049714+ pubmed: 15667143 pmcid: 1360656
Steichen, J. M. et al. Structural basis for the regulation of protein kinase A by activation loop phosphorylation. J. Biol. Chem. 287(18), 14672–14680 (2012).
doi: 10.1074/jbc.M111.335091 pubmed: 22334660 pmcid: 3340281
Mirdita, M., Steinegger, M. & Soding, J. MMseqs2 desktop and local web server app for fast, interactive sequence searches. Bioinformatics. 35(16), 2856–2858 (2019).
doi: 10.1093/bioinformatics/bty1057 pubmed: 30615063 pmcid: 6691333
Leibschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: Recent developments in Phenix. Acta Cryst. D. 75(10), 861–877 (2019).
doi: 10.1107/S2059798319011471
Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30(16), 2785–2791 (2009).
doi: 10.1002/jcc.21256 pubmed: 19399780 pmcid: 2760638
Forli, S. & Meeko https://github.com/forlilab/Meeko (2023).
Schrodinger, L. L. C. The PyMOL molecular graphics system, Version 1.8. (2015).

Auteurs

Jinung Song (J)

College of Pharmacy, Seoul National University, Seoul, Republic of Korea.

Junsu Ha (J)

Arontier Co., Seoul, Republic of Korea.

Juyong Lee (J)

College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Arontier Co., Seoul, Republic of Korea.
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul, Republic of Korea.

Junsu Ko (J)

Arontier Co., Seoul, Republic of Korea.

Woong-Hee Shin (WH)

Arontier Co., Seoul, Republic of Korea. whshin@korea.ac.kr.
Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea. whshin@korea.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH